TransCode Therapeutics Inc.
RNAZ | NASDAQ
$1.76
+$0.11 (+6.67%)
At close: Sep 21, 2026, 4:00 PM ET
$1.76
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:44 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -6.75M | -17.79B | -1.37B | -4.86M | -4.28M | -12.09M | -5.92M | -2.32M | -5.19M | -3.33M | -4.09M | -5.3M | -4.34M | -4.82M | -5.13M | -4.29M | -4.67M | -3.47M | -2.8M | -2.33M | 2.77M | -4.49M |
Depreciation & Amortization | n/a | 23.94M | -6.34M | 4.78K | 13.44K | 51.17K | 122.86K | 127.52K | 142.84K | 141.65K | 140.17K | 138.78K | 137.59K | 100.2K | 29.51K | 24.8K | 22.7K | 21.6K | 28.99K | 7.54K | 4.69K | 1.26K |
Stock-Based Compensation | n/a | n/a | -95.71M | n/a | n/a | 157.73K | 168.77K | 204.48K | n/a | n/a | n/a | 392.33K | 175.48K | 158.76K | 130.56K | 105.6K | 98.6K | 60.57K | 39K | n/a | n/a | 48.43K |
Other Working Capital | n/a | -610.39K | 1.14M | -1.03M | 573.87K | -133K | 930.4K | -767.67K | 656.32K | -250.72K | 61.26K | -696.06K | 1.38M | -891.79K | 217.17K | -1.84M | 1.3M | 117.26K | 572.84K | -2.31M | 292.41K | -442.46K |
Other Non-Cash Items | 6.75M | 12.55B | 1.24B | 413.48K | 293.22K | 9.23M | 1.54M | n/a | 1.14M | 183.15K | 310.31K | -1.15M | 2.06M | n/a | n/a | n/a | 265.92K | n/a | 38.77K | -709.56K | -3.14M | 19.63K |
Deferred Income Tax | n/a | 231.31M | 226.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.15M | -2.06M | n/a | n/a | n/a | -265.92K | n/a | n/a | n/a | n/a | 3.98M |
Change in Working Capital | n/a | 2.12M | 340.58K | 354.61K | -224.5K | -455K | 942.35K | -1.92M | 1.56M | -935.21K | -2.03M | 1.26M | -363.12K | 44.42K | 954.27K | -262.82K | 1.18M | -560.67K | 1.09M | -811.53K | 205.73K | -89.25K |
Operating Cash Flow | n/a | -4.98B | -8.14M | -4.08M | -4.19M | -3.1M | -3.15M | -3.91M | -2.34M | -3.94M | -5.66M | -3.51M | -4.39M | -4.51M | -4.02M | -4.42M | -3.37M | -3.95M | -1.6M | -3.84M | -161.66K | -522.15K |
Capital Expenditures | n/a | -3 | -6.66K | 3 | -1 | n/a | -500 | -12.87K | -4.56K | -3.84K | -1 | -4.61K | -18.11K | -12.9K | -28.22K | n/a | -42.05K | -30.65K | -85.73K | -71.55K | -22.24K | -75.3K |
Cash Acquisitions | n/a | n/a | 2.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | -4.44K | n/a | n/a | n/a | -500 | -12.87K | -4.56K | -3.84K | n/a | -4.61K | -18.11K | -12.9K | -28.22K | n/a | -42.05K | -30.66K | -82.73K | -71.55K | -22.24K | -75.3K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -115K | -1.73B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 115K | 1.73B | 23.12M | -455.73K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 135.8K | -135.8K | n/a | 225.82K | -225.82K | 5.98K | n/a | 9.49K | -29.27K | 160.87K | -131.6K |
Financial Cash Flow | n/a | n/a | 23.12M | -455.73K | n/a | 8.86M | 7.08M | 2.45M | 785.2K | 6.09M | 978.15K | 7.39M | 6.36M | 1.18M | 225.82K | -225.82K | 5.98K | 5.99K | 9.49K | 26.34M | 164.51K | -131.6K |
Net Cash Flow | n/a | -4.98B | 14.98M | -4.54M | -4.19M | 5.76M | 3.94M | -1.48M | -1.56M | 2.15M | -4.69M | 3.88M | 1.95M | -3.35M | -3.82M | -4.65M | -3.41M | -3.97M | -1.67M | 22.42M | -19.4K | -729.05K |
Free Cash Flow | n/a | -4.98B | -8.15M | -4.08M | -4.19M | -3.1M | -3.15M | -3.93M | -2.34M | -3.94M | -5.66M | -3.51M | -4.41M | -4.53M | -4.05M | -4.42M | -3.41M | -3.98M | -1.69M | -3.91M | -183.9K | -597.45K |
Adj. Free Cash Flow | n/a | -4.98B | 87.56M | -4.08M | -4.19M | -3.25M | -3.32M | -4.13M | -2.34M | -3.94M | -5.66M | -3.9M | -4.59M | -4.69M | -4.18M | -4.53M | -3.51M | -4.04M | -1.73M | -3.91M | -183.9K | -645.89K |
Maintenance CapEx | n/a | -3 | -6.66K | -3 | -1 | n/a | -500 | -12.87K | -4.56K | -3.84K | -1 | -4.61K | -18.11K | -12.9K | -28.22K | n/a | -22.7K | -21.6K | -28.99K | -7.54K | -4.69K | -1.26K |
Growth CapEx | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.35K | -9.05K | -56.74K | -64.02K | -17.55K | -74.05K |
Owner Earnings | n/a | -4.98B | -8.15M | -4.08M | -4.19M | -3.1M | -3.15M | -3.93M | -2.34M | -3.94M | -5.66M | -3.51M | -4.41M | -4.53M | -4.05M | -4.42M | -3.39M | -3.97M | -1.63M | -3.85M | -166.36K | -523.41K |
Add to Watchlist
Select watchlists to add or remove RNAZ